Form D · Biotechnology
Genetesis LLC
Mason, OH · CIK 0001676970
Offering snapshot reported Jun 13, 2016 · SEC filing
- Reported sold
- $350K Offering amount: $1.2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 27, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 13, 2016 | Initial | $350,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-264916
Source: Form D, filed Jun 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vineet Erasala | Executive |
| Emmanuel Setegn | Executive |
| Peeyush Shrivastava | Executive |
| Manjit Singh | Executive |
| Chandan Srivastava | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6555 Glenstone Way
Mason, OH, 45040
Mason, OH, 45040